![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 35, 24445-24448, August 27, 1999
,
,
,
,
,
,
, and
From the p21Cip1, first described as an
inhibitor of cyclin-dependent kinases, has recently been
shown to have a function in the formation of cyclin D-Cdk4 complexes
and in their nuclear translocation. The dual behavior of
p21Cip1 may be due to its association with other proteins.
Different evidence presented here indicate an in vitro and
in vivo interaction of p21Cip1 with calmodulin:
1) purified p21Cip1 is able to bind to calmodulin-Sepharose
in a Ca2+-dependent manner, and this binding is
inhibited by the calmodulin-binding domain of
calmodulin-dependent kinase II; 2) both molecules
coimmunoprecipitate when extracted from cellular lysates; and 3)
colocalization of calmodulin and p21Cip1 can be detected
in vivo by electron microscopy immunogold analysis. The
carboxyl-terminal domain of p21Cip1 is responsible for the
calmodulin interaction, since p21145-164 peptide is also
able to bind calmodulin and to compete with full-length p21Cip1 for the calmodulin binding. Because treatment of
cells with anti-calmodulin drugs decreases the nuclear accumulation of
p21Cip1, we hypothesize that calmodulin interaction with
p21Cip1 is important for p21Cip1, and in
consequence for cyclin D-Cdk4, translocation into the cell nucleus.
Departament de Biologia Cel.lular i Anatomia
Patològica, Institut d'Investigacions Biomèdiques August
Pi i Sunyer (IDIBAPS), Facultat de Medicina, Universitat de
Barcelona, 08036 Barcelona, Spain, the ¶ Department of
Pathology, Brigham and Women's Hospital and Harvard Medical School,
Boston, Massachusetts 02115, and the
Departamento de
Bioquímica y Biología Molecular, Universidad de
Valencia, E-46100 Burjassot, Valencia, Spain
This article has been cited by other articles:
![]() |
J. Zhan, J. B. Easton, S. Huang, A. Mishra, L. Xiao, E. R. Lacy, R. W. Kriwacki, and P. J. Houghton Negative Regulation of ASK1 by p21Cip1 Involves a Small Domain That Includes Serine 98 That Is Phosphorylated by ASK1 In Vivo Mol. Cell. Biol., May 1, 2007; 27(9): 3530 - 3541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Choi, A. Chiang, N. Taulier, R. Gros, A. Pirani, and M. Husain A Calmodulin-Binding Site on Cyclin E Mediates Ca2+-Sensitive G1/S Transitions in Vascular Smooth Muscle Cells Circ. Res., May 26, 2006; 98(10): 1273 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yu, J. Megyesi, R. L. Safirstein, and P. M. Price Identification of the functional domain of p21WAF1/CIP1 that protects cells from cisplatin cytotoxicity Am J Physiol Renal Physiol, September 1, 2005; 289(3): F514 - F520. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rodriguez-Vilarrupla, M. Jaumot, N. Abella, N. Canela, S. Brun, C. Diaz, J. M. Estanyol, O. Bachs, and N. Agell Binding of Calmodulin to the Carboxy-Terminal Region of p21 Induces Nuclear Accumulation via Inhibition of Protein Kinase C-Mediated Phosphorylation of Ser153 Mol. Cell. Biol., August 15, 2005; 25(16): 7364 - 7374. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tamori, Y. Yamanishi, S. Kawashima, M. Kanehisa, M. Enomoto, H. Tanaka, S. Kubo, S. Shiomi, and S. Nishiguchi Alteration of Gene Expression in Human Hepatocellular Carcinoma with Integrated Hepatitis B Virus DNA Clin. Cancer Res., August 15, 2005; 11(16): 5821 - 5826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sim, K. Rimmer, S. Kelly, L. M. Ludbrook, A. H. A. Clayton, and V. R. Harley Defective Calmodulin-Mediated Nuclear Transport of the Sex-Determining Region of the Y Chromosome (SRY) in XY Sex Reversal Mol. Endocrinol., July 1, 2005; 19(7): 1884 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Khanna, M. Plummer, V. Nilakantan, and G. M. Pieper Recombinant p21 Protein Inhibits Lymphocyte Proliferation and Transcription Factors J. Immunol., June 15, 2005; 174(12): 7610 - 7617. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cifuentes, J. M. Mataraza, B. A. Yoshida, M. Menon, D. B. Sacks, E. R. Barrack, and G. P.-V. Reddy Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells PNAS, January 13, 2004; 101(2): 464 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Kahl and A. R. Means Regulation of Cell Cycle Progression by Calcium/Calmodulin-Dependent Pathways Endocr. Rev., December 1, 2003; 24(6): 719 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Argentaro, H. Sim, S. Kelly, S. Preiss, A. Clayton, D. A. Jans, and V. R. Harley A SOX9 Defect of Calmodulin-dependent Nuclear Import in Campomelic Dysplasia/Autosomal Sex Reversal J. Biol. Chem., September 5, 2003; 278(36): 33839 - 33847. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. R. Harley, S. Layfield, C. L. Mitchell, J. K. Forwood, A. P. John, L. J. Briggs, S. G. McDowall, and D. A. Jans Defective importin {beta} recognition and nuclear import of the sex-determining factor SRY are associated with XY sex-reversing mutations PNAS, June 10, 2003; 100(12): 7045 - 7050. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Canela, A. Rodriguez-Vilarrupla, J. M. Estanyol, C. Diaz, M. J. Pujol, N. Agell, and O. Bachs The SET Protein Regulates G2/M Transition by Modulating Cyclin B-Cyclin-dependent Kinase 1 Activity J. Biol. Chem., January 3, 2003; 278(2): 1158 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Li, D. Zhang, and K. Fujise Characterization of Fortilin, a Novel Antiapoptotic Protein J. Biol. Chem., December 7, 2001; 276(50): 47542 - 47549. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Villalonga, C. Lopez-Alcala, M. Bosch, A. Chiloeches, N. Rocamora, J. Gil, R. Marais, C. J. Marshall, O. Bachs, and N. Agell Calmodulin Binds to K-Ras, but Not to H- or N-Ras, and Modulates Its Downstream Signaling Mol. Cell. Biol., November 1, 2001; 21(21): 7345 - 7354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Egea, C. Espinet, R. M. Soler, X. Dolcet, V. J. Yuste, M. Encinas, M. Iglesias, N. Rocamora, and J. X. Comella Neuronal survival induced by neurotrophins requires calmodulin J. Cell Biol., August 6, 2001; 154(3): 585 - 598. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. LANG, A. HARTNER, R. B. STERZEL, and H. O. SCHÖCKLMANN Requirement of Cyclin D1 in Mesangial Cell Mitogenesis J. Am. Soc. Nephrol., August 1, 2000; 11(8): 1398 - 1408. [Abstract] [Full Text] |
||||
![]() |
C. Yang, R. T. Watson, J. S. Elmendorf, D. B. Sacks, and J. E. Pessin Calmodulin Antagonists Inhibit Insulin-Stimulated GLUT4 (Glucose Transporter 4) Translocation by Preventing the Formation of Phosphatidylinositol 3,4,5-Trisphosphate in 3T3L1 Adipocytes Mol. Endocrinol., February 1, 2000; 14(2): 317 - 326. [Abstract] [Full Text] |
||||
![]() |
T. Ono, H. Kitaura, H. Ugai, T. Murata, K. K. Yokoyama, S. M. M. Iguchi-Ariga, and H. Ariga TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 Kinase J. Biol. Chem., September 29, 2000; 275(40): 31145 - 31154. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, J. L. Joyal, and D. B. Sacks Calmodulin Enhances the Stability of the Estrogen Receptor J. Biol. Chem., May 11, 2001; 276(20): 17354 - 17360. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Harris, J. H. Albrecht, M. Nakanishi, and G. J. Darlington CCAAT/Enhancer-binding Protein-alpha Cooperates with p21 to Inhibit Cyclin-dependent Kinase-2 Activity and Induces Growth Arrest Independent of DNA Binding J. Biol. Chem., July 27, 2001; 276(31): 29200 - 29209. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |